Alpha Tau Medical Ltd. Warrant (DRTSW)
$3.90
$-0.33
(-7.80%)
As on 09-Sep-2026 15:20EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
5 Years Aggregate
CFO
$-67.81 Mln
EBITDA
$-94.70 Mln
Net Profit
$-107.54 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alpha Tau Medical Ltd. Warrant (DRTSW)
| 1,047.1 | 14.7 | 95.0 | 1,312.5 | 143.5 | -- | -- |
|
BSE Sensex
| -11.7 | -4.8 | 1.7 | -7.5 | 3.9 | 5.1 | 9.9 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Alpha Tau Medical Ltd. Warrant (DRTSW)
| 61.9 | 9.0 | -23.0 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Alpha Tau Medical Ltd. Warrant (DRTSW)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT... technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel. Read more
-
CEO & Chairman
Mr. Uzi Sofer
-
CEO & Chairman
Mr. Uzi Sofer
-
Headquarters
Jerusalem
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Alpha Tau Medical Ltd. Warrant (DRTSW)
What is the current share price of Alpha Tau Medical Ltd Warrant (DRTSW) Today?
The share price of Alpha Tau Medical Ltd Warrant (DRTSW) is $3.90 (NASDAQ) as of 09-Sep-2026 15:20 EDT. Alpha Tau Medical Ltd Warrant (DRTSW) has given a return of 143.54% in the last 3 years.
What is the current PB & PE ratio of Alpha Tau Medical Ltd Warrant (DRTSW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.68 |
0.38 |
2024 |
-0.46 |
0.23 |
2023 |
-0.46 |
0.16 |
2022 |
-0.51 |
0.16 |
2021 |
-- |
-- |
What is the 52 Week High and Low of Alpha Tau Medical Ltd Warrant (DRTSW)?
The 52-week high and low of Alpha Tau Medical Ltd Warrant (DRTSW) are Rs 4.29 and Rs 0.26 as of 10-Sep-2026.
What is the market cap of Alpha Tau Medical Ltd Warrant (DRTSW)?
Alpha Tau Medical Ltd Warrant (DRTSW) has a market capitalisation of -- as on 04-Sep-2026. As per SEBI classification, it is a company.
Should I invest in Alpha Tau Medical Ltd Warrant (DRTSW)?
Before investing in Alpha Tau Medical Ltd Warrant (DRTSW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.